生物種
|
リソース名
|
RRC ID
|
タイトル
|
ジャーナル
|
公開日
|
外部リンク
|
ヒト・動物細胞
|
WEHI-3(RCB0035)
,
Ba/F3(RCB0805)
|
77171
|
Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells.
|
Anticancer Drugs |
2013-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
HS-Sch-2(RCB2230)
|
75809
|
Appropriate modulation of autophagy sensitizes malignant peripheral nerve sheath tumor cells to treatment with imatinib mesylate.
|
J Pediatr Hematol Oncol |
2014-4-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
WI-38(RCB0702)
|
71658
|
Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells.
|
Int J Oncol |
2010-10-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
OP9(RCB1124)
|
68726
|
Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence.
|
Cancer Cell |
2013-3-18 |
Pubmed
Full text
|
ヒト・動物細胞
|
K562
|
44754
|
Inhibition of the PI3K/Akt/GSK3 pathway downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD downregulates DNA damage-induced Chk1 activation as well as G2/M arrest and prominently enhances induction of apoptosis.
|
PLoS One |
2013-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
KU812(RCB0495)
|
44595
|
Imatinib induces demethylation of miR-203 gene: an epigenetic mechanism of anti-tumor effect of imatinib.
|
Leuk Res |
2013-10-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
K562
|
44196
|
PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells.
|
Int J Oncol |
2013-2-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Ba/F3(RCB0895)
|
43640
|
Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa.
|
Int J Hematol |
2012-2-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
MIA Paca2(RCB2094)
,
KP4(RCB1005)
,
PK-45
,
PK-59(RCB1901)
|
43302
|
MEK inhibitor enhances the inhibitory effect of imatinib on pancreatic cancer cell growth.
|
Cancer Lett |
2008-6-18 |
Pubmed
Full text
|
ヒト・動物細胞
|
|
43204
|
Mechanisms for the proliferation of eosinophilic leukemia cells by FIP1L1-PDGFRalpha.
|
Biochem Biophys Res Commun |
2008-2-22 |
Pubmed
Full text
|
ヒト・動物細胞
|
KU812(RCB0495)
,
K562
|
38228
|
Enhancement of imatinib-induced apoptosis of BCR/ABL-expressing cells by nutlin-3 through synergistic activation of the mitochondrial apoptotic pathway.
|
Apoptosis |
2010-5-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
K562
,
KU812(RCB0495)
|
38152
|
A novel FRET-based biosensor for the measurement of BCR-ABL activity and its response to drugs in living cells.
|
Clin Cancer Res |
2010-8-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
KU812(RCB0495)
,
K562
|
37627
|
Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
|
Cancer Res |
2009-5-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
WEHI-3(RCB0035)
|
36972
|
Sensitivity of SNX2-ABL1 toward tyrosine kinase inhibitors distinct from that of BCR-ABL1.
|
Leuk Res |
2014-3-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
TCS(RCB0638)
,
Ca Ski(RCB1947)
|
18640
|
HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancers.
|
Cancer Res |
2011-11-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
K562(RCB0027)
|
1383
|
A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity.
|
Blood |
2004-3-15 |
Pubmed
Full text
|
ヒト・動物細胞
|
K562(RCB0027)
|
1345
|
Inactivation of ERK accelerates erythroid differentiation of K562 cells induced by herbimycin A and STI571 while activation of MEK1 interferes with it.
|
Mol Cell Biochem |
2004-3-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
K562(RCB0027)
|
1344
|
Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells.
|
Leuk Res |
2004-6-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
K562(RCB0027)
|
1343
|
Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect.
|
Anticancer Res |
2004-1-1 |
Pubmed
|